Pathogenesis and Treatment of Lymphedema and Lymphatic Diseases

The summary for the Pathogenesis and Treatment of Lymphedema and Lymphatic Diseases grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pathogenesis and Treatment of Lymphedema and Lymphatic Diseases: The National Heart, Lung, and Blood Institute (NHLBI), National Institute of Child Health and Human Development (NICHD), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Cancer Institute (NCI), National Institute of Nursing Research (NINR), National Center for Complementary and Alternative Medicine (NCCAM), and National Institute on Biomedical Imaging and Bioengineering (NIBIB) invite qualified researchers to submit applications for research project grants to investigate the pathogenesis and new treatments for primary and secondary lymphedema. The purpose of this program announcement is to stimulate research on the biology of the lymphatic system, to characterize at the molecular, cellular, tissue, organ, and intact organism levels, the pathophysiologic mechanisms that cause the disease, to develop new methods for quantitating and imaging lymph flow, to discover new therapeutic interventions, and to determine the safety, efficacy and mechanisms of action of complementary and alternative therapies. The scope of this research includes developmental biology and genetics of the lymphatic system to identify and characterize genes important for its organization and regulation. Such knowledge will help to improve early diagnosis of affected individuals, the choice and timing of treatment, and genetic counseling. Research is also needed on the pathophysiology of the disorders of skin and subcutaneous tissue secondary to chronic lymphedema, and lymphedema which results from cancers and cancer treatment, with an ultimate goal to develop more targeted and effective therapies.
Federal Grant Title: Pathogenesis and Treatment of Lymphedema and Lymphatic Diseases
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-04-071
Type of Funding: Grant
CFDA Numbers: 93.21393.286
CFDA Descriptions: Research and Training in Complementary and Alternative Medicine 93.286 Discovery and Applied Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Mar 08, 2004
Creation Date: Mar 08, 2004
Archive Date: Jan 30, 2007
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.396 -- Cancer Biology Research
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020